OABI – omniab, inc. (US:NASDAQ)
Stock Stats
News
OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
OmniAb to Participate in Five Investor Conferences in May
OmniAb to Report First Quarter 2024 Financial Results on May 9
Form 10-Q OmniAb, Inc. For: Mar 31
Form 8-K OmniAb, Inc. For: May 09
Form ARS OmniAb, Inc. For: Dec 31
Form DEFA14A OmniAb, Inc.
Form DEF 14A OmniAb, Inc. For: Jun 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.